Skip to main content

Narcolepsy Market Research Report and Business Opportunities Forecast to 2027 Leading Players Involved-Bioprojet, Teva Pharmaceutical Industries, Jazz Pharmaceuticals, Graymark Healthcare

Press release   •   Sep 25, 2019 23:34 IST

Narcolepsy Market

According to a new market research study titled 'Narcolepsy Market - Global Analysis and Forecasts by Type, Product and Distribution Channel, the global narcolepsy market is expected to reach US$ 4,537.9 Mn in 2027 from US$ 2,026.8 Mn in 2018. The market is estimated to grow with a CAGR of 9.5% from 2019-2027. The report highlights the trends prevalent in the global narcolepsy market and the factors driving the market along with those that act as deterrents to its growth.

Key factors driving the market are rising prevalence of sleep related disorders, emerging local pharmaceutical & biopharmaceutical companies, and increasing awareness regarding neurological disorders. However, factors such as side effects and risks associated with narcolepsy medications and delayed diagnosis or misdiagnosis of narcolepsy are likely to restrain the market growth to a certain extent.

Get Sample Copy of this Report at - https://www.theinsightpartners.com/sample/TIPRE00003326/

Some of the prominent players operating in Narcolepsy market are:-

Bioprojet, Teva Pharmaceutical Industries Ltd., Jazz Pharmaceuticals, Inc., Graymark Healthcare, Inc., Arena Pharmaceuticals, Inc., Shire (Acquired by Takeda), Ligand Pharmaceuticals, Inc., Novartis AG, Mylan N.V., and Shionogi Inc.

What the report features:-

- Global analysis of Narcolepsy market from 2017 – 2027 illustrating the progression of the market.

- Forecast and analysis of Narcolepsy market by Dosage, Route of Administration and Application from 2017 – 2027

- Forecast and analysis of Narcolepsy market in five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America

The market players are focused towards bringing new and innovative products and services to sustain their position in the market. For instance, in October, 2018, Officials with the FDA have approved Jazz Pharmaceuticals' Xyrem (sodium oxybate) for the treatment of cataplexy and excessive daytime sleepiness in pediatric patients aged 7 to 17 years with narcolepsy. The drug had previously been approved for use in adult patients. The developments performed by the companies are helping the market to grow in the coming years.

Avail Discount on the Report Click at - https://www.theinsightpartners.com/discount/TIPRE00003326/

The narcolepsy market by type is segmented into narcolepsy with cataplexy, narcolepsy without cataplexy, and secondary cataplexy. In 2018, the narcolepsy with cataplexy segment held a largest market share of 65.1% of the narcolepsy market, by type. This segment is also expected to dominate the market in 2027 owing to its significant prevalence among patients suffering with narcolepsy. Episodes of cataplexy are reported to be encountered among 55-60% of patients suffering with narcolepsy. Moreover, the similar segment is anticipated to also witness the fastest growth rate of 9.7% during the forecast period, 2019 to 2027 owing to the increasing demand for drugs to treat the disease.

The target audience for the report on the Narcolepsy market

- Manufactures

- Market analysts

- Senior executives

- Business development managers

- Technologists

- R&D staff

- Distributors

- Investors

- Governments

- Equity research firms

- Consultants

Key Benefits of Buying this Research Study:

- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Narcolepsy Market

- Highlights key business priorities in order to assist companies to realign their business strategies

- The key findings and recommendations highlight crucial progressive industry trends in the Narcolepsy Market, thereby allowing players across the value chain to develop effective long term strategies

- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it

- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

- Examine the political, economic, social and technology impact of the five regions namely: North America, Europe, Asia Pacific, Middle East & Africa and South America.

Purchase this Research Study at - https://www.theinsightpartners.com/buy/TIPRE00003326/

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:

Call: +1-646-491-9876

Email: sales@theinsightpartners.com

Website: www.theinsightpartners.com

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Comments (0)

Add comment

Comment

By submitting the comment you agree that your personal data will be processed according to Mynewsdesk's Privacy Policy.